Upon binding to its ligands, PD-L1 and PD-L2, which are expressed on tumor cells and antigen-presenting cells, PD-1 signaling inhibits T cell proliferation, cytokine production, and cytotoxic activity. The gene discussed is PDCD1; the disease is neoplasm.